Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Augusto Orlandi is active.

Publication


Featured researches published by Augusto Orlandi.


Oncogene | 2010

PARP1 is activated at telomeres upon G4 stabilization: Possible target for telomere-based therapy

Erica Salvati; Marco Scarsella; Manuela Porru; Angela Rizzo; Sara Iachettini; Lucio Tentori; Grazia Graziani; Maurizio D'Incalci; Malcolm F. G. Stevens; Augusto Orlandi; Daniela Passeri; Eric Gilson; Gabriella Zupi; Carlo Leonetti; Annamaria Biroccio

New anti-telomere strategies represent important goals for the development of selective cancer therapies. In this study, we reported that uncapped telomeres, resulting from pharmacological stabilization of quadruplex DNA by RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate), trigger specific recruitment and activation of poly-adenosine diphosphate (ADP) ribose polymerase I (PARP1) at the telomeres, forming several ADP-ribose polymers that co-localize with the telomeric repeat binding factor 1 protein and are inhibited by selective PARP(s) inhibitors or PARP1-specific small interfering RNAs. The knockdown of PARP1 prevents repairing of RHPS4-induced telomere DNA breaks, leading to increases in chromosome abnormalities and eventually to the inhibition of tumor cell growth both in vitro and in xenografts. More interestingly, the integration of a TOPO1 inhibitor on the combination treatment proved to have a high therapeutic efficacy ensuing a complete regression of the tumor as well as a significant increase in overall survival and cure of mice even when treatments started at a very late stage of tumor growth. Overall, this work reveals the unexplored link between the PARP1 and G-quadruplex ligands and demonstrates the excellent efficacy of a multi-component strategy based on the use of PARP inhibitors in telomere-based therapy.


Respiratory Medicine | 2008

HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema

Paola Rogliani; Marco Mura; Paolo Mattia; Amedeo Ferlosio; Gianfranco Farinelli; Salvatore Mariotta; Paolo Graziano; Gabriella Pezzuto; Alberto Ricci; Cesare Saltini; Augusto Orlandi

Idiopathic pulmonary fibrosis has been associated with emphysema in cigarette smokers as a new clinical entity: combined pulmonary fibrosis and emphysema (CPFE). In order to compare histomorphometrical, roentgenological and immunohistochemical aspects of usual interstitial pneumonia (UIP) with and without associated pulmonary emphysema, 17 patients with biopsy-proven UIP were evaluated. Morphometrical evaluation of lung parenchyma destruction was used to divide patients in two subgroups: emphysema/UIP (n=9) and UIP alone (n=8); four patients with biopsy-proven emphysema without fibrosis were also evaluated. At HRTC scan, emphysematous lesions were prevalent in the upper fields of both emphysema/UIP and emphysema groups and the distribution of fibrotic lesions was similar in emphysema/UIP compared to UIP alone. The semiquantitative histopathological fibrotic score was also similar in emphysema/UIP and UIP alone. In addition, the expression of tumor necrosis factor (TNF)-alpha, matrix metalloproteinase (MMP)-2, MMP-9, MMP-7 and membrane type 1-metalloproteinase (MT1-MMP) by fibroblasts of myofibroblastic foci was similar in emphysema/UIP and UIP alone patients. In contrast, fibroblasts in areas of parenchymal destruction of emphysema/UIP expressed MMP-2, MMP-9, MMP-7 and MT1-MMP at variable but significantly higher levels when compared to emphysema subjects, in the presence of similar levels of TIMP-1, TIMP-2 and TNF-alpha. Fibrotic and emphysematous lesions in emphysema/UIP patients appear to follow the roentgenological and histopathological patterns expected for either UIP or emphysema. Interstitial fibroblast activation is more pronounced in the areas of lung destruction in emphysema/UIP compared to those with emphysema alone, as for exaggerated tissue remodeling.


British Journal of Pharmacology | 2011

Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi

Maria Gabriella Matera; Luigino Calzetta; Daniela Passeri; Francesco Facciolo; Erino A. Rendina; Clive P. Page; Mario Cazzola; Augusto Orlandi

BACKGROUND AND PURPOSE Brain natriuretic peptide (BNP) plays an important role in several biological functions, including bronchial relaxation. Here, we have investigated the role of BNP and its cognate receptors in human bronchial tone.


Amino Acids | 2009

Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis

Augusto Orlandi; Francesco Oliva; G. Taurisano; Eleonora Candi; A. Di Lascio; Gerry Melino; Luigi Giusto Spagnoli; Umberto Tarantino

Osteoarthritis is a progressive joint disease characterized by cartilage degradation and bone remodeling. Transglutaminases catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate glutamine residues and modifies the extracellular matrix. Increased transglutaminases-mediated activity is reported in osteoarthritis, but the relative contribution of transglutaminases-2 (TG2) is uncertain. We describe TG2 expression in human femoral osteoarthritis and in wild-type and homozygous TG2 knockout mice after surgically-induced knee joint instability. Increased TG2 levels were observed in human and wild-type murine osteoarthritic cartilage compared to the respective controls. Histomorphometrical but not X-ray investigation documented in osteoarthritic TG2 knockout mice reduced cartilage destruction and an increased osteophyte formation compared to wild-type mice. These differences were associated with increased TGFβ-1 expression. In addition to confirming its important role in osteoarthritis development, our results demonstrated that TG2 expression differently influences cartilage destruction and bone remodeling, suggesting new targeted TG2-related therapeutic strategies.


British Journal of Dermatology | 2006

TREATMENT OF INFLAMMATORY LINEAR VERRUCOUS EPIDERMAL NAEVUS WITH CALCIPOTRIOL

Stefano Gatti; Anna Maria Carrozzo; Augusto Orlandi; Gabriele Nini

white, milk, wheat, soybean, moulds {PeniciUium. Cladosporium. Candida. AUernaria and AspergiUus). mites, ceder, house dust, and Pityrosporum ovale. The condition of her hands improved after she stopped handling and eating rice for 3 weeks. She began to wear rubber gloves whenever she washed rice, and thereafter never suffered from contact urticaria on the hands again. The severity of her atopic dermatitis remained unchanged, even after she started eating rice again. The principal food of the Japanese is hoiled rice. Before cooking it is vigorously hand-washed, and the water is changed several times. The results of the investigations performed in our patient suggest that water-soluble allergens were responsible for producing the contact urticaria. They were proteins which were heat-stable, but degradabic by trypsin digestion. The molecular weight was thought to be between 10 and 30 kDa, but it is possible that there were some antigens larger than 30 kDa.


European Respiratory Journal | 2012

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells

Paola Spitalieri; Maria Chiara Quitadamo; Augusto Orlandi; Lorenzo Guerra; Emiliano Giardina; Valeria Casavola; Giuseppe Novelli; Cesare Saltini; Federica Sangiuolo

Alveolar type II pneumocytes (ATII cells) are considered putative alveolar stem cells. Since no treatment is available to repair damaged epithelium and prevent lung fibrosis, novel approaches to induce regeneration of injured alveolar epithelium are desired. The objective of this study was to assess both the capacity of human embryonic stem cells (HUES-3) to differentiate in vitro into ATII cells and the ability of committed HUES-3 cells (HUES-3-ATII cells) to recover in vivo a pulmonary fibrosis model obtained by silica-induced damage. In vitro differentiated HUES-3-ATII cells displayed an alveolar phenotype characterised by multi-lamellar body and tight junction formation, by the expression of specific markers such as surfactant protein (SP)-B, SP-C and zonula occludens (ZO)-1 and the activity of cystic fibrosis transmembrane conductance regulator-mediated chloride ion transport. After transplantation of HUES-3-ATII cells into silica-damaged mice, histological and biomolecular analyses revealed a significant reduction of inflammation and fibrosis markers along with lung function improvement, weight recovery and increased survival. The persistence of human SP-C, human nuclear antigen and human DNA in the engrafted lungs indicates that differentiated cells remained engrafted up to 10 weeks. In conclusion, cell therapy using HUES-3 cells may be considered a promising approach to lung injury repair.


Oncotarget | 2016

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Monica Benvenuto; Laura Masuelli; Enrico De Smaele; Massimo C. Fantini; Rosanna Mattera; Danilo Cucchi; Elena Bonanno; Enrica Di Stefano; Giovanni Vanni Frajese; Augusto Orlandi; Isabella Screpanti; Alberto Gulino; Andrea Modesti; Roberto Bei

Aberrant Hedgehog (Hh)/glioma-associated oncogene (GLI) signaling has been implicated in cancer progression. Here, we analyzed GLI1, Sonic Hedgehog (Shh) and NF-κB expression in 51 breast cancer (ductal carcinoma) tissues using immunohistochemistry. We found a positive correlation between nuclear GLI1 expression and tumor grade in ductal carcinoma cases. Cytoplasmic Shh staining significantly correlated with a lower tumor grade. Next, the in vitro effects of two Hh signaling pathway inhibitors on breast cancer cell lines were evaluated using the Smoothened (SMO) antagonist GDC-0449 and the direct GLI1 inhibitor GANT-61. GDC-0449 and GANT-61 exhibited the following effects: a) inhibited breast cancer cell survival; b) induced apoptosis; c) inhibited Hh pathway activity by decreasing the mRNA expression levels of GLI1 and Ptch and inhibiting the nuclear translocation of GLI1; d) increased/decreased EGFR and ErbB2 protein expression, reduced p21-Ras and ERK1/ERK2 MAPK activities and inhibited AKT activation; and e) decreased the nuclear translocation of NF-κB. However, GANT-61 exerted these effects more effectively than GDC-0449. The in vivo antitumor activities of GDC-0449 and GANT-61 were analyzed in BALB/c mice that were subcutaneously inoculated with mouse breast cancer (TUBO) cells. GDC-0449 and GANT-61 suppressed tumor growth of TUBO cells in BALB/c mice to different extents. These findings suggest that targeting the Hh pathway using antagonists that act downstream of SMO is a more efficient strategy than using antagonists that act upstream of SMO for interrupting Hh signaling in breast cancer.


Clinical Cancer Research | 2011

DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents

Annamaria Biroccio; Manuela Porru; Angela Maria Rizzo; Erica Salvati; Carmen D'Angelo; Augusto Orlandi; Daniela Passeri; Marco Franceschin; Malcolm F. G. Stevens; Eric Gilson; Giovanni Luca Beretta; Gabriella Zupi; Claudio Pisano; Franco Zunino; Carlo Leonetti

Purpose: We previously reported that the G-quadruplex (G4) ligand RHPS4 potentiates the antitumor activity of camptothecins both in vitro and in tumor xenografts. The present study aims at investigating the mechanisms involved in this specific drug interaction. Experimental Design: Combination index test was used to evaluate the interaction between G4 ligands and standard or novel Topo I inhibitors. Chromatin immunoprecipitation was performed to study the presence at telomeres of various types of topisomerase, while immunolabeling experiments were performed to measure the activation of DNA damage both in vitro and in tumor xenografts. Results: We report that integration of the Topo I inhibitor SN-38, but not the Topo II poison doxorubicin with telomere-based therapy is strongly effective and the sequence of drug administration is critical in determining the synergistic interaction, impairing the cell ability to recover from drug-induced cytotoxicity. The synergistic effect of this combination was also observed by using novel camptothecins and, more interestingly, mice treated with ST1481/RHPS4 combination showed an inhibition and delay of tumor growth as well as an increased survival. The study of the mechanism(s) revealed that treatment with G4 ligands increased Topo I at the telomeres and the functional relevance of this observation was directly assessed by showing that standard and novel camptothecins stabilized DNA damage both in vitro and in xenografts. Conclusions: Our results demonstrate an outstanding efficacy of Topo I inhibitors/G4 ligands combination, which likely reflects an enhanced and persistent activation of DNA damage response as a critical determinant of the therapeutic improvement. Clin Cancer Res; 17(8); 2227–36. ©2011 AACR.


Molecular Cancer Therapeutics | 2008

Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968

Claudio Pisano; Michelandrea De Cesare; Giovanni Luca Beretta; Valentina Zuco; Graziella Pratesi; Sergio Penco; Loredana Vesci; Rosanna Foderà; Fabiana Fosca Ferrara; Mario B. Guglielmi; Paolo Carminati; Sabrina Dallavalle; Lucio Merlini; Augusto Orlandi; Franco Zunino

ST1968 is a novel hydrophilic camptothecin (CPT) derivative of the 7-oxyiminomethyl series. Because ST1968 retained ability to form remarkably stable cleavable complexes, this study was done to investigate its preclinical profile of antitumor activity in a large panel of human tumor models, including irinotecan-resistant tumors. Although less potent than SN38 in vitro, i.v. administered ST1968 caused a marked tumor inhibition, superior to that of irinotecan, in most tested models. ST1968 exhibited an impressive activity against several tumors including models of ovarian and colon carcinoma in which a high rate of cures was observed. In the most responsive tumors, complete and persistent tumor regressions were achieved even with low suboptimal doses. Even tumors derived from intrinsically resistant cells exhibited a significant responsiveness. Histologic analysis of treated tumors supports a contribution of both proapoptotic and antiangiogenic effects to ST1968 antitumor efficacy. A study done in yeast cells transformed with CPT-resistant mutant forms of topoisomerase I documented that, in contrast to other tested CPT, ST1968 was active against yeasts expressing the mutant K720E enzyme. Based on its outstanding efficacy superior to that of irinotecan and of its good therapeutic index, ST1968 has been selected for clinical development. [Mol Cancer Ther 2008;7(7):2051–9]


PLOS ONE | 2014

Sortilin expression is essential for pro-nerve growth factor-induced apoptosis of rat vascular smooth muscle cells.

Luisa Campagnolo; Gaetana Costanza; Arianna Francesconi; Gaetano Arcuri; Ilana Moscatelli; Augusto Orlandi

Background Sortilin, a member of the Vps10p-domain receptor family, has been demonstrated a key regulator in mediating cellular response to pro-neurotrophins. In the present study, we investigated the role of sortilin in the apoptotic pathway of vascular smooth muscle cells. Methods and Principal Findings Immunohistochemistry revealed that sortilin was barely detectable in human and rat normal young vessels, while its expression was increased in human fibroatheromatous plaques. Sortilin immunodetection was also marked in the neointima of the rat aorta fifteen days after ballooning. In vitro, rat aortic intimal cells expressed higher sortilin levels than normal media SMCs; sortilin was distributed in the cytoplasm and in correspondence of the cell membrane. After 48 h, pro-nerve growth factor (proNGF) induced the strong dose-dependent increase of intimal cell apoptosis and the accumulation of sortilin protein. ProNGF was a more potent apoptotic inducer than equimolar or even higher concentration of NGF, whereas brain derived neutrotrophic factor was ineffective. Targeted interfering RNA-mediated sortilin reduction counteracted proNGF-induced apoptosis without affecting p75NTR expression. ProNGF-induced apoptosis was associated to NF-κB down-regulation and bax increase. Inhibition of NF-κB activity increased intimal cell apoptosis that did not further increase with the addition of proNGF. Conclusions Our results indicate that sortilin expression characterizes human atheromatous lesions and rat aortic post-injury neointima, and suggest that sortilin represents an important regulator of proNGF-induced SMC apoptosis and arterial remodeling.

Collaboration


Dive into the Augusto Orlandi's collaboration.

Top Co-Authors

Avatar

Luca Bianchi

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Elena Campione

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Sergio Chimenti

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Daniela Passeri

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Laura Diluvio

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Luigi Giusto Spagnoli

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Maria Giovanna Scioli

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Amedeo Ferlosio

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Pietro Gentile

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Elena Bonanno

University of Rome Tor Vergata

View shared research outputs
Researchain Logo
Decentralizing Knowledge